ASIT-biotech is rated 3 out of 5 in the category biotechnology. Read and write reviews about ASIT-biotech. ASIT biotech is a Belgian clinical stage biopharmaceutical company focused on the development and future commercialisation of a range of breakthrough immunotherapy products for the treatment of allergies. Thanks to its innovative ASIT+TM technology platform, ASIT biotech is currently the only developer of AIT product candidates consisting of a unique mixture of highly purified natural allergen fragments in an optimal size selection. This innovation results in a short treatment, expected to improve patient compliance and real-life effectiveness.
Address
rue des Chasseurs Ardennais 7
Company size
11-50 employees
Headquarters
Angleur, Liège